8189 — Tianjin Teda Biomedical Engineering Share Price
Last trade - 00:00- HK$501.47m
- HK$558.15m
- CNY522.97m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 17.83 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 5.9 | ||
| Price to Sales | 0.72 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -169.89% | ||
| Return on Equity | -123.03% | ||
| Operating Margin | -10.95% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 476.38 | 403.73 | 398 | 385.48 | 522.97 | n/a | n/a | 7.2% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tianjin TEDA Biomedical Engineering Co Ltd is a China-based company primarily engaged in the manufacture and sale of biological compound fertiliser products. The Company mainly operates its business through two segments. The Fertiliser Products segment is engaged in the manufacture and sale of biological compound fertiliser products, including active fertiliser, mixture with nitrogen, phosphorus and potassium with various formula, providing warehousing services and processing and licensing of the fertiliser products. The Elderly Care & Health Care Services segment is engaged in the provision of integrated elderly care and health care services, including the leasing of elderly equipment. The Company mainly conducts its business in the domestic market.
Directors
- Li Sun CHM (42)
- Zhihui Hao VCH (53)
- Shuxin Wang EDR (50)
- Ka Kuen Ng SEC (54)
- Kin Sang Chan NID (63)
- Tong Guan NID (46)
- Chen Wu NID (70)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- September 8th, 2000
- Public Since
- June 18th, 2002
- No. of Employees
- 273
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 2,133,900,000
- Address
- 9F, Block A2 Tianda High-tech Park No.80, TIANJIN, 300457
- Web
- http://www.bioteda.com
- Phone
- +86 2259816900
- Auditors
- Fan, Chan & Co. Limited
Latest News for 8189
Upcoming Events for 8189
Full Year 2026 Tianjin TEDA Biomedical Engineering Co Ltd Earnings Release
Similar to 8189
Befar
Stock Exchange of Hong Kong Limited
China Gas Industry Investment Holdings
Stock Exchange of Hong Kong Limited
Zhejiang ChangAn Renheng Technology
Stock Exchange of Hong Kong Limited
Changmao Biochemical Engineering
Stock Exchange of Hong Kong Limited
China Longevity
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 05:41 UTC, shares in Tianjin Teda Biomedical Engineering are trading at HK$0.24. This share price information is delayed by 15 minutes.
Shares in Tianjin Teda Biomedical Engineering last closed at HK$0.24 and the price had moved by -38.16% over the past 365 days. In terms of relative price strength the Tianjin Teda Biomedical Engineering share price has underperformed the FTSE Developed Asia Pacific Index by -54.83% over the past year.
There is no consensus recommendation for this security.
Find out moreTianjin Teda Biomedical Engineering does not currently pay a dividend.
Tianjin Teda Biomedical Engineering does not currently pay a dividend.
Tianjin Teda Biomedical Engineering does not currently pay a dividend.
To buy shares in Tianjin Teda Biomedical Engineering you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.24, shares in Tianjin Teda Biomedical Engineering had a market capitalisation of HK$501.47m.
Here are the trading details for Tianjin Teda Biomedical Engineering:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 8189
Based on an overall assessment of its quality, value and momentum Tianjin Teda Biomedical Engineering is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tianjin Teda Biomedical Engineering. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -20.39%.
As of the last closing price of HK$0.24, shares in Tianjin Teda Biomedical Engineering were trading -3.84% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tianjin Teda Biomedical Engineering PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.24.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Tianjin Teda Biomedical Engineering's management team is headed by:
- Li Sun - CHM
- Zhihui Hao - VCH
- Shuxin Wang - EDR
- Ka Kuen Ng - SEC
- Kin Sang Chan - NID
- Tong Guan - NID
- Chen Wu - NID